Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_67034276f098d54f09a24cd68c0124a1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f248844230aa1f5a254f31755a94f9f6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c6edc482191cfbe6674903997311872d |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2875 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6863 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-715 |
filingDate |
2005-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a710ae97ef1ee9a6abc62ba55b15734 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8dbeee48b1461ff6e04c5e75213ce829 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b15e544e3398627d4dc540738873a7b2 |
publicationDate |
2006-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2006127985-A1 |
titleOfInvention |
Cytokine designated 4-1BB ligand and human receptor that binds thereto |
abstract |
Novel 4-1BB ligand (4-1BB-L) polypeptides and a human cell surface receptor designated 4-1BB that binds 4-1BB-L are provided. Isolated 4-1BB-L-encoding and human 4-1BB-encoding DNA sequences, recombinant expression vectors comprising the isolated DNA sequences, and host cells transformed with the recombinant expression vectors are disclosed, along with methods for producing the novel polypeptides by cultivating such transformed host cells. Soluble forms of the 4-1BB-L or 4-1BB polypeptides are derived from the extracellular domains thereof. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8475790-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006182744-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008118501-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10017782-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10155038-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017112811-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008260706-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008019905-A9 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011104049-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8859229-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011229460-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018199595-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006188439-A1 |
priorityDate |
1993-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |